Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-026660
Filing Date
2020-10-01
Accepted
2020-10-01 16:06:25
Documents
1
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3634
  Complete submission text file 0000899243-20-026660.txt   5176
Mailing Address 280 S. MANGUM STREET SUITE 350 DURHAM NC 27701
Business Address
INGRAM ROBERT ALEXANDER (Reporting) CIK: 0001219890 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39200 | Film No.: 201215941

Mailing Address 139 MAIN STREET CAMBRIDGE MA 02142
Business Address 139 MAIN STREET CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)